GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organigram Global Inc (NAS:OGI) » Definitions » Gross Profit

OGI (Organigram Global) Gross Profit : $39.7 Mil (TTM As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Organigram Global Gross Profit?

Organigram Global's gross profit for the three months ended in Dec. 2024 was $9.7 Mil. Organigram Global's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was $39.7 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Organigram Global's gross profit for the three months ended in Dec. 2024 was $9.7 Mil. Organigram Global's Revenue for the three months ended in Dec. 2024 was $30.0 Mil. Therefore, Organigram Global's Gross Margin % for the quarter that ended in Dec. 2024 was 32.33%.

Organigram Global had a gross margin of 32.33% for the quarter that ended in Dec. 2024 => Competition eroding margins

During the past 12 years, the highest Gross Margin % of Organigram Global was 415.42%. The lowest was -65.08%. And the median was 29.73%.


Organigram Global Gross Profit Historical Data

The historical data trend for Organigram Global's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organigram Global Gross Profit Chart

Organigram Global Annual Data
Trend Apr14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Sep24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.52 -42.70 -22.54 24.44 35.08

Organigram Global Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.99 7.09 10.22 12.71 9.70

Competitive Comparison of Organigram Global's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Organigram Global's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organigram Global's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organigram Global's Gross Profit distribution charts can be found below:

* The bar in red indicates where Organigram Global's Gross Profit falls into.


;
;

Organigram Global Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Organigram Global's Gross Profit for the fiscal year that ended in Sep. 2024 is calculated as

Gross Profit (A: Sep. 2024 )=Revenue - Cost of Goods Sold
=117.999 - 82.916
=35.1

Organigram Global's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=29.992 - 20.296
=9.7

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $39.7 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Organigram Global's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=9.7 / 29.992
=32.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Organigram Global  (NAS:OGI) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Organigram Global had a gross margin of 32.33% for the quarter that ended in Dec. 2024 => Competition eroding margins


Organigram Global Gross Profit Related Terms

Thank you for viewing the detailed overview of Organigram Global's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Organigram Global Business Description

Traded in Other Exchanges
Address
145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds brands, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.